Company Encyclopedia
View More
name
ProShares Ultra Health Care ETF
RXL.US
News
View More

First Trust Advisors LP Sells 21,347 Shares of Amgen Inc. $AMGN

First Trust Advisors LP reduced its stake in Amgen Inc. by 3.8% in Q2, selling 21,347 shares. Amgen's stock opened at $340.16, with a market cap of $183.17 billion. The company reported Q3 earnings of $5.64 per share, beating estimates, and announced a quarterly dividend of $2.38. Insiders sold shares, including EVP Murdo Gordon and SVP Rachna Khosla.

Market Beat·
US
AMGN
-1.52%
Market Beat·
US
AMGN
-1.52%

AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant Advanced Ovarian Cancer

An AbbVie-sponsored symposium at ESMO Asia 2025 addressed the critical need for new strategies to define and treat platinum resistance in advanced ovarian cancer. Experts highlighted that platinum-resistant advanced ovarian cancer has a poor prognosis and current treatment options are limited and often accompanied by significant side effects, affecting patients' quality of life. The discussion emphasized exploring novel approaches, including Antibody Drug Conjugates (ADCs), to improve efficacy, tolerability, and patient outcomes in this challenging disease.

PR Newswire·
US
ABBV
-0.66%
PR Newswire·
US
ABBV
-0.66%

Amundi Has $1.35 Billion Stock Position in Intuitive Surgical, Inc. $ISRG

Amundi reduced its stake in Intuitive Surgical by 24.7% in Q2, now holding 2,488,028 shares valued at $1.35 billion. Other institutional investors like Norges Bank and Vanguard Group have also adjusted their positions. Analysts have varied ratings on Intuitive Surgical, with a consensus price target of $607.17. Insider transactions include significant stock sales by executives. Intuitive Surgical's stock opened at $568.63, with a market cap of $203.84 billion.

Market Beat·
US
ISRG
-0.19%
Market Beat·
US
ISRG
-0.19%

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026

Netflix completed a 10-for-1 stock split, making shares more accessible at around $100 each. This move could increase Netflix's chances of joining the Dow Jones Industrial Average. Meta Platforms, ASML, and Eli Lilly are predicted to issue stock splits in 2026, making them attractive growth stocks to buy in December. Meta could replace Verizon in the Dow, ASML is poised for technological advancements in AI chips, and Eli Lilly's success is driven by its GLP-1 medications.

Motley Fool·
US
NFLX
-0.71%
US
ASML
-2.70%
US
META
+3.43%
Motley Fool·
US
NFLX
-0.71%
US
ASML
-2.70%
US
META
+3.43%

Glucose monitor problems linked with deaths, injuries: FDA

The FDA has linked at least seven deaths and hundreds of injuries to malfunctioning glucose monitors by Abbott Diabetes Care. The issue affects about 3 million FreeStyle Libre 3 and Libre 3 Plus devices, traced to one production line. Incorrect low glucose readings may lead to serious health risks. Abbott has reported 736 severe adverse events and is replacing affected sensors. The company has identified the issue's source and expects no major supply disruptions.

Thehill·
US
ABT
+0.09%
Thehill·
US
ABT
+0.09%
© 2025 Longbridge｜Disclaimer